Dyslipidemia: Nutrition and Nutritional Supplement Strategies

The primary underlying causes of 80 percent of the cases of dyslipidemia are inflammatory macro and micronutrient intake, chronic infections and toxins. Metabolic endotoxemia and the micobiome are important in the pathogenesis of dyslipidemia. This lecture will review the pathogenesis of dyslipidemic –induced vascular disease as it relates to modified LDL, LDL particle number, LDL particle size, macrophage uptake of modified LDL, scavenger receptors, HDL particle number, size, functionality and reverse cholesterol transport and downstream mediators of inflammation, oxidative stress and immune vascular dysfunction. A detailed review of all labs that provide advanced lipid testing will be discussed. Attendees will learn a clinical integrative approach to the treatment of dyslipidemia using nutrition, lifestyle changes, exercise, weight loss, nutritional supplements and anti‐lipid medications to decrease cardiovascular disease (CVD) such as angina, coronary heart disease (CHD), stroke, peripheral vascular disease (PAD) and atherosclerosis. A new revolutionary approach to prevent dyslipidemic‐induced vascular disease using the development of 38 new mechanisms that cause vascular disease will be discussed and treatment of each of these will be provided.